A Phase IV Post Marketing Prospective Observational Cohort Study of Polyvalent Antivenom (Premium-PANAF) for Snakebite Envenoming in Ethiopia

The study is expected to provide important data on the safety and effectiveness of Premium-PANAF, the only WHO recommended panafrican snake antivenom for Sub-Saharan Africa. These results will help inform national and international protocols and p...